Two studies demonstrate that natural killer T-cell adjuvants, covalently attached to either carbohydrate or peptide epitopes, yield effective vaccines.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to the full article PDF.
USD 39.95
Prices may be subject to local taxes which are calculated during checkout

References
Cavallari, M. et al. Nat. Chem. Biol. 10, 950–956 (2014).
Anderson, R.J. et al. Nat. Chem. Biol. 10, 943–949 (2014).
Steinhagen, F., Kinjo, T., Bode, C. & Kinman, D.M. Vaccine 29, 3341–3355 (2011).
Rossjohn, J., Pellicci, D.G., Patel, O., Gapin, L. & Godfrey, D.I. Nat. Rev. Immunol. 12, 845–857 (2012).
Carreño, L.J., Kharkwal, S.S. & Porcelli, S.A. Immunotherapy 6, 309–320 (2014).
King, I.K. et al. Nat. Immunol. 13, 44–50 (2012).
Tonti, E. et al. J. Immunol. 188, 3217–3222 (2012).
Astronomo, R.D. & Burton, D.R. Nat. Rev. Drug Discov. 9, 308–324 (2010).
Enomoto, N. et al. J. Immunol. 188, 1734–1741 (2012).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The author declares no competing financial interests.
Rights and permissions
About this article
Cite this article
Savage, P. NKT-cell adjuvants in conjugate. Nat Chem Biol 10, 882–883 (2014). https://doi.org/10.1038/nchembio.1667
Published:
Issue date:
DOI: https://doi.org/10.1038/nchembio.1667